Heron Therapeutics, Inc. (NASDAQ:HRTX)
Heron Therapeutics, Inc. (NASDAQ:HRTX) represented a move of -3.63 percent or $0.67 per share and closed its previous day trading session at $29.98. 1.29 Million Shares were traded in the last trading session with an Average Volume of 989.08 Million Shares. The stock currently has a Market Capitalization of 2.4 Billion.
Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.
The stock traded between $14.95 and $42.90 over 1-Year time period showing its price to sales ratio of 50.63. Heron Therapeutics, Inc. (NASDAQ:HRTX) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-5.95 and 200-Day Simple Moving Average of $-4.11. Its Price to Free Cash Flow is 0 and Price to Book of 5.
Analyst’s recommended the stock as 1.7 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Heron Therapeutics, Inc. (NASDAQ:HRTX) reported its Actual EPS of $-0.49/share. The analysts offering Earnings Estimates for the company were believing that Heron Therapeutics, Inc. could bring EPS of $-0.45/share. The difference between Actual EPS and Estimated EPS was -0.04 Percent. Thus showing an Earnings Surprise of -8.9 Percent.
aTyr Pharma, Inc. (NASDAQ:LIFE)
In the last trading session, aTyr Pharma, Inc. (NASDAQ:LIFE) added its value by 6.21% closing at the price of $0.68. The stock currently has market capitalization of 19.61 Million, with average volume of 451.37 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently aTyr Pharma, Inc. (NASDAQ:LIFE) is showing beta of 2.92. This particular value of beta suggests that aTyr Pharma, Inc. (NASDAQ:LIFE) has historically moved 292% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for aTyr Pharma, Inc. (NASDAQ:LIFE) is at $-1.53.
The stock currently has RSI of 51.66. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.
aTyr Pharma, Inc. (NASDAQ:LIFE) topped its 52-week high price of $4.350 on 12/04/17 and 52-Week Low Price of $0.590 on 10/31/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 9.44% and monthly volatility of 9.11% respectively.